Mobile

A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers

Update Il y a 4 ans
Reference: NCT01731327

Woman and Man

  • | Country :
  • Singapore
  • | organs :
    • -
  • | Specialty :
    • -

Extract

This study will explore the drug behavior and safety following single doses of tofacitinib modified-release (MR) 11 mg and MR 22 mg in healthy volunteers.

Inclusion criteria

  • Healthy

Links